Clinical Trial Update: To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion [Phase 4]

View source ↗

Summary

Clinical trial update evaluating afatinib for NRG1 fusion–positive non-small cell lung cancer in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: NRG1-fused Non-small Cell Lung Cancer | Phase 4 | Status: UNKNOWN